Novak J S, Tabita F R
Department of Microbiology and Plant Molecular Biology/Biotechnology Program, The Ohio State University, 484 West 12th Avenue, Columbus, Ohio, 43210-1292, USA.
Arch Biochem Biophys. 1999 Mar 15;363(2):273-82. doi: 10.1006/abbi.1998.1084.
The cbbPI and cbbPII genes from Rhodobacter sphaeroides, encoding highly similar phosphoribulokinase (PRK) isozymes, PRK I and PRK II, respectively, exhibited differential allosteric activation by NADH. The two cbbP genes were cloned into expression vectors and homogeneous recombinant protein prepared. PRK II was found to be inherently less stable than PRK I; however, the addition of substrate ATP resulted in the complete protection of both isozymes to a 15-min incubation at 50 degrees C. The relative molecular masses for both octameric isozymes were determined to be approximately 230,000; however, the protective effect of ATP was in accordance with aggregation of monomers to a molecular mass of approximately 750,000. While PRK I exhibited a nearly absolute dependence upon NADH for activity, PRK II retained substantial activity in the absence of NADH. PRK chimeras were thus constructed to facilitate elucidation of the basis for the differential effect of NADH, with advantage taken of the relative sequence identity of about 90% between the two isozymes. Chimeras were constructed either by in vivo homologous recombination, using the sacB gene from Bacillus subtilis as a conditionally lethal marker, or by using convenient restriction sites to combine different parts of the two cbbP genes. The PRK chimeras generated contained either the amino-terminal domain of PRK II and the carboxy-terminal domain of PRK I or the opposite configuration. Subsequent analyses of the chimeras pointed to particular regions and residue(s) as likely being important for NADH activation.
来自球形红杆菌的cbbPI和cbbPII基因分别编码高度相似的磷酸核酮糖激酶(PRK)同工酶PRK I和PRK II,它们表现出由NADH引起的变构激活差异。将这两个cbbP基因克隆到表达载体中,并制备了均一的重组蛋白。发现PRK II本质上比PRK I更不稳定;然而,添加底物ATP可使两种同工酶在50℃下孵育15分钟时得到完全保护。两种八聚体同工酶的相对分子质量测定约为230,000;然而,ATP的保护作用与单体聚合成约750,000的分子质量一致。虽然PRK I的活性几乎绝对依赖于NADH,但PRK II在没有NADH的情况下仍保留大量活性。因此构建了PRK嵌合体,以利于阐明NADH差异效应的基础,利用了两种同工酶之间约90%的相对序列同一性。嵌合体通过体内同源重组构建,使用来自枯草芽孢杆菌的sacB基因作为条件致死标记,或者通过使用方便的限制性位点来组合两个cbbP基因的不同部分。产生的PRK嵌合体包含PRK II的氨基末端结构域和PRK I的羧基末端结构域,或者相反的构型。随后对嵌合体的分析指出特定区域和残基可能对NADH激活很重要。